Preconception phthalate exposure and offspring outcomes
Preconception phthalate exposure and offspring outcomes
批准号:
10246409
负责人:
MARISA S. BARTOLOMEI
金额:
$44.1万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-09-01 至 2023-08-31
关键词:
ATAC-seqAdipocytesAdultAdult ChildrenAnimal ModelAnimalsAwarenessBeta CellBiologicalBiological AssayBody fatBone DensityBrainCellsChromatinComplementDNA MethylationDataDevelopmentDiabetes MellitusDietDiethylhexyl PhthalateDoseEmbryoEndocrineEndocrine DisruptorsEnergy MetabolismEnvironmental ExposureEnvironmental PollutionEpigenetic ProcessEstersExposure toFetal LiverFetusFood ProcessingGeneral PopulationGenesHepatocyteHumanIndustrializationLactationLeadLifeLinkLiverMeasuresMembrane PotentialsMemoryMessenger RNAMetabolicMetabolic syndromeMicroRNAsMitochondriaMitochondrial DNAMolecularMorphologyMuscleMuscle CellsNeurologicObesityOocytesOrganOutcomeOxidative PhosphorylationPhenotypePhysiologicalPredispositionPregnancyProductionProteinsRespirationRiskRisk AssessmentSourceTissuesUntranslated RNAWeightWeight GainWestern Blottingbehavior changebehavioral phenotypingbisulfite sequencingblood glucose regulationchromatin immunoprecipitationcritical perioddietaryepigenomehuman modelinsulin secretioninsulin sensitivitylight microscopymetabolic phenotypemitochondrial dysfunctionneurobehavioralobesity developmentobesogenicoffspringphthalatesprenatal exposurepyrosequencingsextranscriptometranscriptome sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Endocrine disruptors (EDs) are a group of molecules capable of altering normal endocrine
function in animals and humans. We and others have demonstrated that in utero exposure to
EDs causes obesity and abnormal glucose homeostasis in the offspring. Phthalates are an
important group of EDs that are used in a diverse range of industrial applications leading to
common exposure risk in humans. One major phthalate is di-(2-ethylhexyl)-phthalate (DEHP), a
widely used compound for which dietary exposure (food processing, packaging) likely
represents the main source of contamination for the general population. Both human and animal
models show a link between phthalate exposure and the development of obesity and the
metabolic syndrome. Similar to these studies, our preliminary data show that DEHP exposure
through the diet in physiologically relevant doses prior to and during pregnancy and lactation
alters DNA methylation in fetal liver, increases body weight in adult offspring in a sex-specific
manner. It is becoming increasingly evident that the periconceptional stage also represents a
window of susceptibility to environmental exposures on the offspring. While the mechanisms
responsible for the transfer of metabolic memory from the oocyte to the offspring remain to be
elucidated, 2 plausible possibilities are epigenetic dysregulation and abnormal mitochondria.
Further, we and others have shown that epigenetic changes and abnormal mitochondrial
function in key organs such as the liver, ß-cell and muscle have been linked to development of
obesity and diabetes. Thus, we hypothesize that a preconception exposure to DEHP, similar to
a gestational exposure, results in an abnormal metabolic phenotype in the offspring by altering
either the epigenetic profile and or mitochondrial function in the oocyte. Thus we propose the
following specific aims: Aim 1 will determine whether a preconception exposure to biologically
relevant doses of DEHP results in a similar offspring phenotype as a gestational exposure. Aim
2 will determine the molecular and cellular mechanisms by which the two different exposure
windows result in a similar or different metabolic phenotype in the offspring. We will profile the
transcriptome by RNA-seq and the epigenome by ATACseq and bisulfite-seq in the oocyte and
key tissues in the offspring. We will then determine the effects of DEHP on key aspects of
mitochondrial function such as respiration, ATP, ROS, and morphology. The proof of the
principle of preconception programming by environmental contaminants may change our
awareness of critical assessment of the risk of such compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of TET1 in germ cell reprogramming and development
-
批准号:10467364
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2022
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Role of TET1 in germ cell reprogramming and development
-
批准号:10689734
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2022
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Tri-Institutional Symposium on Reproductive Biology & Infertility (Tri-Repro)
-
批准号:10171876
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2020
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Tri-Institutional Symposium on Reproductive Biology & Infertility (Tri-Repro)
-
批准号:10405090
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2020
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Tri-Institutional Symposium on Reproductive Biology & Infertility (Tri-Repro)
-
批准号:10626897
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2020
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Preconception phthalate exposure and offspring outcomes
-
批准号:9759938
-
项目类别:
-
资助金额:$46.28万
-
财政年份:2017
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Preconception phthalate exposure and offspring outcomes
-
批准号:9362020
-
项目类别:
-
资助金额:$48.3万
-
财政年份:2017
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Long-term physiological and behavioral outcomes, epigenetic profiles and multigenerational phenotypes in a mouse ART model
-
批准号:10152633
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2017
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Long-term physiological and behavioral outcomes, epigenetic profiles and multigenerational phenotypes in a mouse ART model
-
批准号:9921459
-
项目类别:
-
资助金额:$33.41万
-
财政年份:2017
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Sequences controlling H19 Gene Imprinting
-
批准号:9534673
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2016
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Sequences controlling H19 Gene Imprinting
-
批准号:9982067
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2016
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Transgenerational effects of endocrine disruptors: epigenetics and physiology
-
批准号:8728237
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2013
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Transgenerational effects of endocrine disruptors: epigenetics and physiology
-
批准号:8598720
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Transgenerational effects of endocrine disruptors: epigenetics and physiology
-
批准号:9321821
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2013
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Transgenerational Effects of Drug-exposure: Epigenetic and Behavioral Impact
-
批准号:8308736
-
项目类别:
-
资助金额:$45.68万
-
财政年份:2012
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Transgenerational Effects of Drug-exposure: Epigenetic and Behavioral Impact
-
批准号:8828642
-
项目类别:
-
资助金额:$40.32万
-
财政年份:2012
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Transgenerational Effects of Drug-exposure: Epigenetic and Behavioral Impact
-
批准号:9036969
-
项目类别:
-
资助金额:$40.11万
-
财政年份:2012
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Transgenerational Effects of Drug-exposure: Epigenetic and Behavioral Impact
-
批准号:8449603
-
项目类别:
-
资助金额:$38.9万
-
财政年份:2012
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Transgenerational Effects of Drug-exposure: Epigenetic and Behavioral Impact
-
批准号:8637962
-
项目类别:
-
资助金额:$40.52万
-
财政年份:2012
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
Penn Center for Study of Epigenetics in Reproduction
-
批准号:8446929
-
项目类别:
-
资助金额:$146.52万
-
财政年份:2011
-
负责人:MARISA S. BARTOLOMEI
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: